发明名称 New aminoalkyl-substd. core cpds.
摘要 Aminoalkyl-substd. cpds. of formula( (X);-(core moiety) (I) are new j=1-3; (core moiety) = a non-cyclic, cyclic or heterocyclic moiety, where a cyclic or heterocyclic core moiety comprises at least one 4-7-membered ring; x= a racemic mixt, R or S enantiomer, solvate, hydrate or salt of R1R2N-(CH2)n-*CH(OR3)-(CH2)-m (II) or (III) *C= a chiral C atom; n=1-4; one or more C atoms of (CH2)n may be substd. by a keto or OH gp, m=4-14; R1R2=H, alkane or alkene of up to 12C or (CH2)wR5; or jointly R1 and R2 form a substd. or unsubstd. satd. or unsatd. heterocyclic gp. of 4-8C w=2-14; R5=mono-, di- or tri-substd. or unsubstd. aryl gp. substits. on R5 being selected from OH,Cl,F,Br or 1-6C alkoxy; R3= H or 1-3C alkyl; R4=H, alkane or alkene of up to 8C, (CH2)wR5 or a substd. or unsubstd. satd, or unsatd. heterocyclic gp. having 4-8C; r,s=1-4; (r+s) is not greater than 5; t=1-14; one or more C atoms of (CH2)s or (CH2)t may be substd. by a keto or OH gp.
申请公布号 CH686830(A5) 申请公布日期 1996.07.15
申请号 CH19940003711 申请日期 1994.03.31
申请人 CELL THERAPEUTICS, INC. 发明人 MICHNICK, JOHN;UNDERINER, GAIL E.;KLEIN, J. PETER;RICE, GLENN C.;SUNKARA, PRASAD
分类号 A61K31/13;A61K31/135;A61K31/165;A61K31/40;A61K31/4015;A61K31/403;A61K31/4035;A61K31/445;A61K31/45;A61K31/47;A61K31/472;A61K31/505;A61K31/513;A61K31/517;A61K31/519;A61K31/52;A61K31/522;A61P29/00;A61P31/04;A61P35/00;A61P37/06;C07C215/08;C07C215/56;C07C217/62;C07C229/22;C07C233/36;C07C233/78;C07C233/91;C07C237/06;C07D207/40;C07D207/404;C07D207/408;C07D209/48;C07D211/40;C07D211/76;C07D211/88;C07D217/24;C07D239/54;C07D239/90;C07D239/96;C07D295/13;C07D473/10;C07D519/00;(IPC1-7):C07D473/04;C07D487/04;C07C215/02 主分类号 A61K31/13
代理机构 代理人
主权项
地址